StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Don't forget there were less cases in the 2nd quarter

<< Previous

Bullboard Posts

Next >>

Comment by Thisguyiscoolon Aug 17, 2021 9:29am

145 Views

Post# 33716062

RE:Don't forget there were less cases in the 2nd quarter

[ Q2 revenue was low when compared to q1, but with the way covid and testing was playing out, i dont think anyone reasonable was expecting to see an increase from q1.... Delta should add in the next quarters, but szls is all about the cancer trsting. And were seeing good growth there quote=Hobbs999]https://www.worldometers.info/coronavirus/country/us/
It only started to pickup in july.[/quote]

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland